It causes the downregulation of cyclin B1 and phosphorylated Cdc-2 and the upregulation of p21WAF1/Cip1 in endometrial cancer cells, which correlates with G2/M arrest and p53 activation [43]. Here, TP53 is linked to endometrial cancer.